PharmaTimes - June 2017

As the polls tighten and June’s general election starts to seem very close indeed, we’ve got a roundup of all the major parties’ manifestos and what they would mean for healthcare in the UK. But whatever the differences between them, the fear remains – voiced by no less an authority than health economist John Appleby from the Nuffield Trust – that, without extra funding, they simply won’t match up to what the health service needs.

Elsewhere in this issue we take a special look at the pharmaceutical supply chain, asking whether the industry is up to the challenge of the current, and new, era healthcare, while managing at the same time the stresses of demand variability and lower margins.

Meanwhile, there’s careers and strategic insights from some of this month’s ‘SmartPeople’, with Sanofi’s UK and Ireland’s Hugo Fry telling us about his journey to become the firm’s general manager, and how these are transitional times for the French company’s Surrey-based affiliate.

June 2017 - magazine highlights

Realising potential

Richard Baderin, head of commercial enterprises at Accreti...

Haemophilia

Laurence Woollard talks to PharmaTimes about life with a r...

Sales 2.0

Engaging digital while retaining a human touch

Adapting to change

Sanofi’s general manager for the UK and Ireland Hugo Fry o...

NHS-pharma partnerships

Improving the care of diabetes patients at City Hospitals...

How can pharma help the NHS harness the power of data?

Sue Thomas, Paul Midgley and Steve How, of Wilmington Heal...

Is Trump’s choice as FDA Commissioner good for pharma?

What does the nomination of Dr Scott Gottlieb mean for dru...

Supplying for tomorrow’s needs

The pharmaceutical supply chain is facing both challenges...

Propelled by digital disruption

Investing in digital supply chain capabilities has the pot...